Mannkind (MNKD) Accounts Payables (2010 - 2026)
Mannkind (MNKD) reported Accounts Payables of $16.1 million for Q1 2026, up 220.25% year-over-year from $5.0 million in Q1 2025, and up 78.7% quarter-over-quarter from $9.0 million in Q4 2025.
Mannkind (MNKD) Accounts Payables (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Accounts Payables data on file, last reported at $16.1 million in Q1 2026.
- Accounts Payables for Q1 2026 came in at $16.1 million, up 220.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.1 million (up 220.25% YoY), and the FY2025 annual result was $9.0 million, up 33.01% from the prior year.
- Accounts Payables rose to $16.1 million in Q1 2026 per MNKD's latest filing, from $9.0 million in the prior quarter.
- Over five years, Accounts Payables peaked at $17.1 million in Q2 2023 and troughed at $5.0 million in Q1 2025.
- A 5-year average of $10.1 million and a median of $9.6 million in 2024 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2024 and 2026: Accounts Payables slumped 61.54% in 2024, then surged 220.25% in 2026.
- A 5-year view of Accounts Payables shows it stood at $11.1 million in 2022, then retreated by 13.32% to $9.6 million in 2023, then retreated by 29.1% to $6.8 million in 2024, then soared by 33.01% to $9.0 million in 2025, then surged by 78.7% to $16.1 million in 2026.
- Business Quant data shows MNKD's Accounts Payables at $16.1 million in Q1 2026, $9.0 million in Q4 2025, and $7.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 8.64 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 34.55 Mn |
| 10 | Mannkind | 1.13 Bn | 995.19 Mn | 82.66 Mn | 16.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.14 Mn |
| Dec 31, 2025 | 9.03 Mn |
| Sep 30, 2025 | 7.27 Mn |
| Jun 30, 2025 | 10.26 Mn |
| Mar 31, 2025 | 5.04 Mn |
| Dec 31, 2024 | 6.79 Mn |
| Sep 30, 2024 | 6.44 Mn |
| Jun 30, 2024 | 9.56 Mn |
| Mar 31, 2024 | 7.15 Mn |
| Dec 31, 2023 | 9.58 Mn |
| Sep 30, 2023 | 16.75 Mn |
| Jun 30, 2023 | 17.13 Mn |
| Mar 31, 2023 | 13.89 Mn |
| Dec 31, 2022 | 11.05 Mn |
| Sep 30, 2022 | 9.87 Mn |
| Jun 30, 2022 | 7.82 Mn |
| Mar 31, 2022 | 8.70 Mn |
| Dec 31, 2021 | 6.96 Mn |
| Sep 30, 2021 | 9.53 Mn |
| Jun 30, 2021 | 7.49 Mn |